Duke University Health System Innovation

Duke University Health System Innovation is the innovation hub within Duke Health that supplies early-stage capital to researchers and entrepreneurs commercializing novel therapeutic technologies. Its focus areas are medical devices and biotech, anchored to the research output of Duke. AI is not a stated thesis area.

The group invests at pre-seed and seed with $250K to $1M check sizes. The capital is small by absolute standards but strategically valuable for academic spinouts that need bridge funding to reach a meaningful inflection point. The implied geographic scope is U.S. and especially the Research Triangle, given Duke’s institutional gravity in Durham.

Founders likely to fit are typically Duke faculty, postdocs, or licensees of Duke IP, or external founders running early collaborations with Duke clinicians. Expect diligence to integrate with Duke’s tech transfer process and emphasize scientific rigor, IP position, and a credible early development plan. External founders should connect through formal Duke channels rather than purely cold venture outreach. Limited public information is available about deal volume.